Seaport Therapeutics, Inc. Common Stock (SPTX) — Net Asset Momentum
Seaport Therapeutics, Inc. Common Stock (SPTX) recorded a net asset momentum of -272.4% as of December 2025, with net assets of $-92.55 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore SPTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Seaport Therapeutics, Inc. Common Stock Net Asset Momentum (2024–2025)
This chart tracks Seaport Therapeutics, Inc. Common Stock's year-over-year net asset growth across 2 annual reporting periods from 2024 to 2025. The most recent momentum reading is -272.4%, with net assets of $-92.55 Million USD as of December 2025. See Seaport Therapeutics, Inc. Common Stock financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Net Asset History for Seaport Therapeutics, Inc. Common Stock (2024–2025)
The table below shows the complete annual net asset history for Seaport Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Seaport Therapeutics, Inc. Common Stock stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-92.55 Million | $249.01 Million | $341.55 Million | ▼ -272.4% |
| 2024 | $-24.85 Million | $315.78 Million | $340.63 Million | — |